• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, June 3, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Higher mortality rate for Porton Down veterans involved in chemical weapons research

Bioengineer by Bioengineer
May 11, 2023
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Military veterans involved in chemical warfare agent research at Porton Down faced a 6% higher mortality rate than similar veterans who were not involved.

Chemical warfare

Credit: Lancaster University

Military veterans involved in chemical warfare agent research at Porton Down faced a 6% higher mortality rate than similar veterans who were not involved.

The research from the King’s Centre for Military Health Research (KCMHR) at King’s College London, in partnership with Lancaster University, is published in the International Journal of Epidemiology.

Researchers compared the medical records of 16,721 male UK veterans who participated in the ‘Service Volunteer Programme’ from 1941-1989, comparing them with 16,228 non-Porton Down veterans, placing a particular focus on the most common causes of death and types of cancer.

They found that these military veterans had higher rates of mortality from diseases of the genitourinary systems (for example, kidney disease), as well as deaths attributable to alcohol, but found little evidence of an association between attendance at Porton Down and higher rates of overall cancer incidence.

Porton Down first opened during World War I in response to the use of chemical weapons. Since 1916, over 20,000 service personnel have exposed to low doses of chemical warfare agents and their antidotes, some of which are known to be carcinogenic. This has raised questions over the long-term impacts on the health of veterans attached to the Program.

While there was only a small increased risk overall, the researchers did find that veterans who took part in the Porton Down Volunteer Program between 1960-64 were at significantly greater risk of dying from a range of causes including cancerous tumours, diseases within the circulatory system, and smoking related deaths.

The researchers suggest that health providers need to be aware of the specific health issues connected to military veterans, and the wider population, who may have been exposed to chemical warfare agents.

Dr Tom Keegan, one of the study’s authors and a Senior Lecturer in Epidemiology from Lancaster Medical School said: “Military personnel were exposed to over four hundred different types of chemicals over the course of the programme, so we now want to investigate whether particular chemicals are associated with increased risk of poorer health.”

Dr Gemma Archer, from KCMHR, the study’s first author said: “Veterans of the Porton Down Service Volunteer Program were often exposed to small doses of chemical agents designed to be used in war. Our study followed the health of veterans for over fifty years, and we are thankful that it indicates that the large majority of veterans were unlikely to have come to harm. A small number of veterans did appear to have higher rates of death and a variety of other illnesses, and it is something that healthcare professionals need to be mindful of when treating victims of chemical exposure.” 

Professor Nicola Fear, co-director of KCMHR and the study’s senior author said: “There has, for some time, been a question mark hanging over the volunteers who contributed to the research of Porton Down. While it is reassuring that our study found no evidence of increased risk of cancer in veterans who attended Porton Down, the 6% higher rate of all-cause mortality compared to veterans who didn’t attend Porton Down is not something that should be overlooked”.

 

 

 

 

 



Journal

International Journal of Epidemiology

DOI

10.1093/ije/dyad050

Method of Research

Data/statistical analysis

Subject of Research

Not applicable

Article Title

Mortality and cancer incidence in UK military veterans involved in human experiments at Porton Down: 48-year follow-up

Article Publication Date

11-May-2023

COI Statement

none

Share12Tweet8Share2ShareShareShare2

Related Posts

Shubham Pant, M.D.

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

June 3, 2023
Dr. James Harding

For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

June 2, 2023

Results of SWOG S1929 trial show patients with small-cell lung cancer with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade

June 2, 2023

Scientists reveal new details of cellular process which prevents spread of cancer

June 2, 2023

POPULAR NEWS

  • plants

    Plants remove cancer causing toxins from air

    40 shares
    Share 16 Tweet 10
  • Element creation in the lab deepens understanding of surface explosions on neutron stars

    36 shares
    Share 14 Tweet 9
  • Deep sea surveys detect over five thousand new species in future mining hotspot

    35 shares
    Share 14 Tweet 9
  • How life and geology worked together to forge Earth’s nutrient rich crust

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer

For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

Startups to unveil cutting-edge point-of-care technologies at Boston medtech event

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 50 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In